Raymond James Financial’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$109M Sell
2,232,366
-325,797
-13% -$15.2M 0.03% 478
2025
Q4
$112M Sell
2,558,163
-520,179
-17% -$23.7M 0.03% 461
2025
Q3
$139M Sell
3,078,342
-158,286
-5% -$6.95M 0.04% 378
2025
Q2
$141M Buy
3,236,628
+1,204,364
+59% +$53.6M 0.05% 353
2025
Q1
$93.6M Buy
2,032,264
+1,387,134
+215% +$58M 0.04% 460
2024
Q4
$24.3M Buy
+645,130
New +$25M 0.01% 1173

Other funds holding EXC

Raymond James Financial's EXC Position: Q1 2026 in Review

Raymond James Financial reduced its Exelon (EXC) stake by 13% in Q1 2026, selling an estimated $15.2M and leaving 2,232,366 shares worth $109M. The position accounts for 0.03% of the portfolio, ranked #478.

Raymond James Financial first reported a position in EXC in Q4 2024 and has held it in 6 quarters since. The position peaked at $141M in Q2 2025. 1,281 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • Raymond James Financial held 2,232,366 shares of Exelon worth $109M as of Q1 2026.
  • Raymond James Financial sold 325,797 Exelon shares in Q1 2026, an estimated $15.2M.
  • Exelon made up 0.03% of Raymond James Financial's portfolio in Q1 2026, its #478 holding.
  • Raymond James Financial first reported a position in Exelon in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Exelon position peaked at $141M in Q2 2025.
  • 1,281 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.